About the review
Learn about the HTA Review and why it’s important.
Governance
Learn about how the HTA Review Reference Committee oversaw the review.
Consultations
Find out about our consultation activities and stakeholder responses.
Research and analysis papers
Read the papers that HTA experts developed to support the HTA Review.
Final report
The HTA Review concluded on 4 May 2024. The HTA Review Reference Committee held its final meeting on 2 May 2024 and provided its final report to the Minister for Health and Aged Care on 31 May 2024.
We released the final report in September 2024 along with a summary of recommendations and a full recommendations document. These documents supplement the full report by including a summary of the key recommendations and their aims.
The Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC) have considered the final report of the HTA Review and provided their initial advice and reflections to the government.
The government has established an Implementation Advisory Group to develop a roadmap for sequencing the government’s response to the recommendations.
Thank you to everyone who contributed to the review.
Contact
HTA Review Secretariat
Related work
Co-design of consumer engagement for HTA
This co-design aims to increase the patient and consumer voice in the HTA process.
National Medicines Policy
How we work with stakeholders to ensure Australians have fair and affordable access to medicines.
HTA Consumer Consultative Committee
This committee provides strategic advice from a consumer perspective.